Issue 2/2018
Content (3 Articles)
Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters
Lidija Todorović, Boban Stanojević, Vesna Mandušić, Nina Petrović, Vladan Živaljević, Ivan Paunović, Aleksandar Diklić, Vladimir Saenko, Shunichi Yamashita
Genetic polymorphisms associated with adverse reactions of molecular-targeted therapies in renal cell carcinoma
Kazuhiro Yamamoto, Ikuko Yano
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas
Roberto Castelli, Luigi Bergamaschini, Giorgio Lambertenghi Deliliers